TickerFacts.

Company research / NUVB

Nuvation Bio Inc. (NUVB)

Build a valuation ↗↓ Download CSV

CIK 0001811063 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Nuvation Bio Inc. reported revenue of $62.90M. Revenue grew 699.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $169.90M.

Key ratios (year ended 2025-12-31)

-338.7%
Operating margin
-325.3%
Net margin
-66.9%
Return on year-end equity
699.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-21

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$169.90M$62.90M$7.87M$0n/an/an/a
Cost of Revenuen/an/a$7.08M$0n/an/an/a
Gross Profitn/an/a$795.0K$0n/an/an/a
R&D Expense$128.85M$115.11M$99.12M$71.29M$87.81M$69.04M$32.60M
Operating Income-$137.63M-$213.06M-$592.63M-$99.82M-$119.73M-$93.32M-$43.55M
Depreciation & Amortization$2.15M$1.74M$683.0K$222.0K$199.0K$184.0K$103.0K
EBITDA-$135.48M-$211.32M-$591.94M-$99.60M-$119.53M-$93.13M-$43.45M
Net Income-$149.83M-$204.63M-$567.94M-$75.80M-$104.20M-$86.85M-$41.66M
EPS (Diluted)n/a-$0.60-$2.11-$0.35-$0.48-$0.44n/a
Total Assets$744.50M$594.82M$540.63M$621.48M$672.14M$776.15M$221.79M
Total Liabilities$490.64M$289.11M$76.84M$16.36M$17.07M$30.15M$6.71M
Long-Term Debt$242.62M$47.21Mn/an/an/an/an/a
Shareholders' Equity$253.86M$305.72M$463.79M$605.12M$655.08M$746.00M$215.08M
Cash & Equivalents$258.60M$164.09M$35.72M$42.65M$101.10M$132.42M$29.75M
Operating Cash Flow-$120.52M-$173.43M-$130.41M-$68.00M-$96.11M-$68.19M-$36.53M
Shares Outstanding346.50M337.84M337.84M219.05M218.63M217.95M149.04M
EPS (Basic)n/a-$0.60-$2.11-$0.35-$0.48-$0.44n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView